Making the case for CT screening for lung cancer

Mark your calendars for Wednesday, April 30. That’s the day that representatives from the American College of Radiology (ACR), the Lung Cancer Alliance and a number of other organizations will go before the 2014 Medicare Evidence Development and Coverage Advisory Committee (MedCAC) seeking to make the case for national Medicare coverage of low dose CT (LDCT) screening for patients at high risk for lung cancer.

The meeting comes after a December 2013 recommendation from the U.S. Preventive Services Task Force (USPSTF) that annual screening with LDCT be given to asymptomatic adults aged 55 to 80 who have a 30 pack-year smoking history and currently smoke or quit within the last 15 years.

The USPSTF’s recommendation was grade “B,” which under the Affordable Care Act means that private insurers must cover the procedure without a co-pay. The healthcare reform law, however, does not compel Medicare to provide full national coverage for such recommendations, setting the stage for next week’s meeting.

In the meeting notes posted online, the Centers for Medicare & Medicaid Services (CMS) said it would be particularly interested in evidence that would help identify which Medicare patients would most likely benefit from screening as well as the appropriate frequency and duration of screening. CMS also will be looking to understand the impact of false positive results and follow-up testing.

Hopefully Ella Kazerooni, MD, chair of the ACR Committee on Lung Cancer Screening, and others speaking in favor of coverage are up to the task, as full Medicare coverage of LDCT screening could save many lives. The results of the National Lung Screening Trial, which factored heavily in USPSTF’s recommendation, showed that CT lung cancer screening in a high-risk population can significantly reduce lung cancer deaths by as much as 20 percent.

We’ll be following the meeting live, and if you want to listen in, you can view the full-day discussion at http://www.cms.gov/live/ starting at 7:30 a.m. EDT on April 30.

-Evan Godt
Editor – Health Imaging

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.